Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA; email:
Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan 48109, USA; email:
Annu Rev Med. 2022 Jan 27;73:423-438. doi: 10.1146/annurev-med-042320-125832. Epub 2021 Sep 23.
The field of endoscopic bariatric and metabolic therapy has rapidly evolved from offering endoscopic treatment of weight regain following bariatric surgery to providing primary weight loss options as alternatives to pharmacologic and surgical interventions. Gastric devices and remodeling procedures were initially designed to work through a mechanism of volume restriction, leading to earlier satiety and reduced caloric intake. As the field continues to grow, small bowel interventions are evolving that may have some effect on weight loss but focus on the treatment of obesity-related comorbidities. Future implementation of combination therapy that utilizes both gastric and small bowel interventions offers an exciting option to further augment weight loss and alleviate metabolic disease. This review considers gastric devices and techniques including space-occupying intragastric balloons, aspiration therapy, endoscopic tissue suturing, and plication interventions, followed by a review of small bowel interventions including endoluminal bypass liners, duodenal mucosal resurfacing, and endoscopically delivered devices to create incisionless anastomoses.
内镜减重和代谢治疗领域已经迅速发展,从提供减重手术后体重反弹的内镜治疗,发展到提供作为药物和手术干预替代方案的主要减肥选择。胃内装置和重塑手术最初是通过容积限制机制设计的,从而更早地产生饱腹感并减少热量摄入。随着该领域的不断发展,小肠干预措施也在不断发展,这些干预措施可能对减肥有一定效果,但侧重于治疗肥胖相关的合并症。未来实施联合治疗,利用胃内和小肠干预措施,为进一步增加减肥效果和缓解代谢性疾病提供了令人兴奋的选择。本文综述了胃内装置和技术,包括占位性胃内球囊、吸引治疗、内镜组织缝合和折叠干预,然后综述了小肠干预措施,包括腔内旁路衬垫、十二指肠黏膜表面重建和内镜输送装置以创建无切口吻合。